Back to Trades
Plump Andrew Stewart
PresidentR&DDirectorCIK 0001977689
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 3
- Companies
- 1
- Active
- 2026
Plump Andrew Stewart, President, R&D, Director, has filed 5 SEC reports (2026), all concentrated in TAKEDA PHARMACEUTICAL CO LTD (TAK), totaling $5.3M in disclosed volume. Weighing $0 bought versus $5.3M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Sep 3 | TAK TAKEDA PHARMACEUTICAL CO LTD | Plump Andrew Stewart | President, R&D, Director | Sell | $2.1M |
| Aug 21 | TAK TAKEDA PHARMACEUTICAL CO LTD | Plump Andrew Stewart | President, R&D, Director | Sell | $363.3K |
| Aug 12 | TAK TAKEDA PHARMACEUTICAL CO LTD | Plump Andrew Stewart | President, R&D, Director | Sell | $2.8M |
| Jul 6 | TAK TAKEDA PHARMACEUTICAL CO LTD | Plump Andrew Stewart | President, R&D, Director | Grant | $0 |
| Apr 28 | TAK TAKEDA PHARMACEUTICAL CO LTD | Plump Andrew Stewart | President, R&D, Director | Grant | $0 |
5 filings